This one-hour, on-demand, journal article-based activity examines how Medicaid unwinding (the resumption of normal Medicaid eligibility checks) affected buprenorphine treatment for opioid use disorder (OUD). This study assesses changes in both new and ending treatment episodes following Medicaid disenrollment.

This one-hour, on-demand, journal article-based activity examines how the Consultation for Addiction Care and Treatment in Hospitals (CATCH) program impacts the delivery of medications for opioid use disorder (MOUD) during hospitalization across six New York City public hospitals.

This 2-hour online course covers treating stimulant use disorder by using interactive, case-based learning to teach evidence-based practices.

This one-hour, on-demand, journal article-based activity explores the use of buprenorphine to treat opioid use disorder while considering risks and potential disengagement. This article focuses on the transition to extended-release or long-acting buprenorphine to improve outcomes and treatment adherence.

This one-hour, on-demand, journal article-based activity examines the relationship between methadone dosing during the first week of treatment and 30-day treatment retention. This article addresses early dropout challenges and offers solutions to patients' adherence to treatment.

This one-hour, on-demand, journal article-based activity reviews findings from a systematic review and meta-analysis on the effectiveness and safety of naltrexone as a standalone pharmacotherapy for amphetamine-type stimulant use disorder (ATSUD). Drawing from five randomized controlled trials, the article examines naltrexone’s impact on stimulant use, study retention, craving, and adverse effects.

This one-hour, on-demand, journal article-based activity explores liver injuries linked to medications used in the treatment of alcohol use disorder (AUD), based on findings from the Drug-Induced Liver Injury Network (DILIN) study. The activity reviews clinical patterns, implicated drugs, and outcomes, offering insights that can inform safer prescribing practices and monitoring strategies in the care of individuals with AUD.

This 75-hour on-demand conference includes 64 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.

This 75-minute on-demand session from the ASAM 56th Annual Conference addresses the mechanisms, current uses, and emerging evidence for GLP-1 receptor agonists in the treatment of substance use disorders, including nicotine, stimulants, and alcohol.

This 75-minute on-demand session from the ASAM 56th Annual Conference addresses advanced knowledge of OUD treatment initiation, including different novel ways to initiate buprenorphine using methadone, XR buprenorphine, and naloxone, through a case-based discussion of pros and cons and regulatory considerations for each approach such as the 72-hour rule of methadone dispensing.